Hormone Replacement Therapy Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

The Global hormone replacement therapy (HRT) market is expected to rise at a high CAGR during the forecast period, 2024-2028. Growing prevalence of other hormonal imbalance disorders which are common among people of various developing countries in the world are expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. Growth in global geriatric population and certain hormonal disorders such as andropause, hyperthyroidism, hypothyroidism, and others which are associated with people during their elder age are expected to propel the growth of hormone replacement therapy market across the world in the forecast period. Furthermore, improvement in worldwide healthcare infrastructure which are leading to innovations in hormone replacement therapy are further expected to register an impressive growth to global hormone replacement therapy market in the forecast period.

Hormone Replacement Therapy (HRT) is a medical treatment that involves replacing the hormones that are produced in lower quantities in the body especially after treatment of certain types of cancer and menopause in women. Various types of hormone replacement therapy that are commonly performed across the world includes estrogen-only therapy, combination therapy, transdermal therapy, and bioidentical hormone therapy.

The United States of America, Canada, Australia, and several European countries such as France, Italy, and Sweden account for highest number of hormone replacement therapies performed among their population in the forecast period. Several health conditions that can be efficiently managed by hormone replacement therapy in the human body comprise of menopause symptoms, osteoporosis, hypogonadism, gender dysphoria, endometriosis, and breast cancer.

Rising Prevalence of Hormonal Imbalance Disorders

Hormonal imbalance disorders can be referred to development of certain health conditions which are caused by abnormality in the production, regulation, and function of hormones in the human body. Some of the hormonal imbalance disorders which can affect both men and women includes polycystic ovary syndrome (PCOS), thyroid disorders, adrenal disorders, pituitary gland disorders, reproductive disorders, parathyroid disorders, and others. Major risk factors which can lead to development of hormonal imbalances in a person include genetic predisposition, age, lifestyle choices, medical conditions, and environmental changes.

Among various hormonal disorders, polycystic ovary syndrome (PCOS) is one of the most prevalent hormonal disorders affecting women of reproductive age. It is estimated that PCOS affects 5-10% of women of reproductive age worldwide. South Asia, Middle East, and North Africa are some of the regions which account for highest number of PCOS cases in recent years. According to the report published by BMC on Reproductive Biology and Endocrinology in 2021, it has been observed that India stood at highest position for around 22.7% PCOS cases being diagnosed in the country, followed by 20% cases in Philippines, 15.9% cases in Australia, 13.7% cases in United Kingdom, 12.2% cases in United States of America, and so on.

Hormone Replacement Therapy involves taking synthetic hormones to replace the hormones that are not being produced adequately by the body. In case of polycystic ovary syndrome (PCOS), hormone replacement therapy is used to regulate menstrual cycles, reduce hair growth, and remove acne. Another common hormonal disorders which are prevailing people of every age group and gender worldwide are thyroid disorders such as hypothyroidism and hyperthyroidism. According to World Health Organization (WHO), around 750 million people are suffering from some form of thyroid disorder in the world. The prevalence of thyroid disorders increases with age which account for around 20% women over 60 years of age having some form of thyroid dysfunction. In some regions, such as Southeast Asia, Africa, and South America around 50% of people are diagnosed with iodine deficiency every year which leads to the development of goiter (enlarged thyroid gland) and hypothyroidism. Moreover, effective results in management of various hormonal disorders after hormone replacement therapy are expected to register an impressive growth of global hormone replacement therapy market in the forecast period.

Growth in Geriatric Population

With increase in age, people tend to develop more symptoms of various hormonal imbalance disorders in their body. Some of the most common hormonal imbalances which affect people during their elder age include menopause, hypothyroidism, andropause, adrenal insufficiency, and diabetes. Among various hormonal disorders, menopause accounts for highest number of instances across various developing countries of the world. According to Menopause Foundation of Canada, by 2025, more than 1 billion women in the world will be experiencing menopause. Various kind of symptoms which are experienced by people during menopause comprise of hot flushes, vaginal dryness, night sweats, weight gain, and others. According to the report published by Forth with Life in 2019, it has been observed that around 73% of people suffer from hot flushes during menopause followed by 63% of people suffering from drowsiness, 47% people from low concentration, 43% people from memory troubles, and so on. Moreover, growth in worldwide geriatric population and rise in certain hormonal imbalances which are associated with people during their elder age are further expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population.

Development of Healthcare Infrastructure

Improvement in medical facilities provided by various hospitals and medical centers around the world is one of the significant factors which is expected to propel the growth of global hormone replacement therapy market in the forecast period. Moreover, establishment of various healthcare associations around the world along with availability of skilled healthcare professionals are allowing more people to undergo hormone replacement therapy in their individual countries which is thereby driving the growth of the market.

Market Segmentation

Global hormone replacement therapy market is segmented based on product, route of administration, disease type, company, and region. In terms of product, the global hormone replacement therapy market is categorized into estrogen and progesterone replacement therapy, HGH replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and parathyroid hormone replacement. Based on, route of administration, the global hormone replacement therapy market is segmented into oral, parenteral, transdermal, and others. Based on disease type, the market is segmented into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and hypoparathyroidism.

Market Players

Bayer AG, Pfizer Inc., Merck & Co., Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), ASCEND Therapeutics US, LLC. (Besins Healthcare), and AbbVie Inc.

Report Scope

In this report, Global Hormone Replacement Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Hormone Replacement Therapy Market, by Product:

• Estrogen and Progesterone Replacement Therapy
• HGH replacement therapy
• Thyroid hormone replacement therapy
• Testosterone Replacement Therapy
• Parathyroid Hormone replacement

Hormone Replacement Therapy Market, by Route of Administration:

• Oral
• Parenteral
• Transdermal
• Others

Hormone Replacement Therapy Market, by Disease Type:

• Menopause
• Hypothyroidism
• Male hypogonadism
• Growth hormone deficiency
• Hypoparathyroidism

Global Hormone Replacement Therapy Market, by region:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hormone Replacement Therapy Market

Available Customization

The following customization option is available based on your specific needs: Detailed analysis and profiling of additional market players (up to five).


This product will be delivered within 1-3 business days.